Boxer Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Boxer Capital Management LLC
CRD #330106
SEC #801-130351
CIK #0001465837, 0002018299
AUM $1.4 B (2025-03-31)
Employees 19 (58% Investors, 0% Brokers)
Phone858-400-3115
Address12860 El Camino Real, Ste 300
San Diego, CA 92130
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($B)
3.02.41.81.20.60.02011201620212026
Sector Form 13F Holdings Value ($B)
BCTG Acquisition Corp 0.1
Revolution Medicines Inc 0.0
Replimune Group Inc 0.0
Merus NV 0.0
Kymera Therapeutics Inc 0.0
Uniqure NV 0.0
Iteos Therapeutics Inc 0.0
UroGen Pharma Ltd 0.0
Amylyx Pharmaceuticals Inc 0.0
Glycomimetics Inc 0.0
View All
Holdings by Sector ($B)
4.03.22.41.60.80.02015201820222026
Type Form D Funds Date Sold ($M) AUM ($M)
HF Boxer Capital Master Fund LP 2025-03-31 0.0
HF Boxer Capital LLC 2024-10-11 1,390.0
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 2 1.4
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 2 1.4
By Discretionary
Discretionary 2 1.4
Non-Discretionary 0 0.0
Total 2 1.4
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 1.4
Total 2 1.4
EDGAR Form CIK 2011 - 2025
13F-HR [0001465837]
3 [0001465837]
4 [0001465837]
SC 13D [0001465837]
SC 13G [0001465837]
13F-HR [0002018299]
3 [0002018299]
4 [0002018299]
Form 13D/13G Filer Form 13D/13G Subject Filed
Boxer Capital LLC Instil Bio Inc [2024-09-27]
Boxer Capital LLC Uniqure NV [2024-07-18]
Boxer Capital LLC Century Therapeutics Inc [2024-04-22]
Boxer Capital LLC Fate Therapeutics Inc [2024-02-12]
Boxer Capital LLC Nkarta Inc [2024-01-18]
Boxer Capital LLC Springworks Therapeutics Inc [2022-09-19]
Boxer Capital LLC TYRA Biosciences Inc [2021-09-24]
Boxer Capital LLC Elevation Oncology Inc [2021-07-09]
Boxer Capital LLC F-Star Therapeutics Inc [2021-05-17]
Boxer Capital LLC RAIN Therapeutics Inc [2021-05-03]
Boxer Capital LLC Biomea Fusion Inc [2021-04-30]
Boxer Capital LLC Talis Biomedical Corp [2021-02-26]
Boxer Capital LLC Merus NV [2021-01-20]
Boxer Capital LLC Silverback Therapeutics Inc [2020-12-17]
Boxer Capital LLC PMV Pharmaceuticals Inc [2020-09-30]
Boxer Capital LLC CymaBay Therapeutics Inc [2020-09-24]
Boxer Capital LLC Iteos Therapeutics Inc [2020-08-07]
Boxer Capital LLC Milestone Pharmaceuticals Inc [2020-08-03]
Boxer Capital LLC Pandion Therapeutics Inc [2020-07-30]
Boxer Capital LLC Therapeutics Acquisition Corp [2020-07-20]
Boxer Capital LLC IDEAYA Biosciences Inc [2020-06-29]
Boxer Capital LLC Syndax Pharmaceuticals Inc [2020-05-11]
Boxer Capital LLC Mereo Biopharma Group PLC [2020-03-02]
Boxer Capital LLC Arcus Biosciences Inc [2020-02-13]
Boxer Capital LLC Black Diamond Therapeutics Inc [2020-02-13]
Boxer Capital LLC Revolution Medicines Inc [2020-02-13]
Boxer Capital LLC Trillium Therapeutics Inc [2020-02-03]
Boxer Capital LLC Marinus Pharmaceuticals Inc [2019-12-13]
Boxer Capital LLC Cabaletta Bio Inc [2019-11-07]
Boxer Capital LLC Bellicum Pharmaceuticals Inc [2019-08-26]
Boxer Capital LLC Atreca Inc [2019-07-01]
Boxer Capital LLC Cellectar Biosciences Inc [2019-05-28]
Boxer Capital LLC DBV Technologies Sa [2018-12-31]
Boxer Capital LLC Matinas Biopharma Holdings Inc [2018-11-08]
Boxer Capital LLC Wave Life Sciences Ltd [2018-06-29]
Boxer Capital LLC Solid Biosciences Inc [2018-05-18]
Boxer Capital LLC Esperion Therapeutics Inc [2018-05-11]
Boxer Capital LLC Rigel Pharmaceuticals Inc [2018-04-23]
Boxer Capital LLC Sunesis Pharmaceuticals Inc [2018-03-05]
Boxer Capital LLC GTX Inc /DE/ [2018-02-20]
Boxer Capital LLC Viking Therapeutics Inc [2018-02-12]
Boxer Capital LLC PTC Therapeutics Inc [2018-01-26]
Boxer Capital LLC Rocket Pharmaceuticals Inc [2018-01-19]
Boxer Capital LLC Aradigm Corp [2017-12-11]
Boxer Capital LLC Odonate Therapeutics Inc [2017-12-08]
Boxer Capital LLC Macrogenics Inc [2017-06-12]
Boxer Capital LLC Esperion Therapeutics Inc [2017-03-23]
Boxer Capital LLC Bellerophon Therapeutics Inc [2017-03-01]
Boxer Capital LLC Medicines Co /DE [2016-11-22]
Boxer Capital LLC Eleven Biotherapeutics Inc [2016-05-25]
Boxer Capital LLC Celladon Corp [2015-12-24]
Boxer Capital LLC Celsus Therapeutics PLC [2015-08-28]
Boxer Capital LLC Mirati Therapeutics Inc [2013-11-04]
Boxer Capital LLC Aradigm Corp [2013-09-25]
Boxer Capital LLC Sophiris Bio Inc [2013-08-26]
Boxer Capital LLC Aradigm Corp [2013-05-30]
Boxer Capital LLC Alexza Pharmaceuticals Inc [2012-02-27]
Form 3/4/5 Subject 2011 - 2025
Boxer Capital Management, LLC
Tango Therapeutics, Inc.
Davis Aaron I.
Tyra Biosciences, Inc.
Lewis Joseph
iTeos Therapeutics, Inc.
Boxer Capital, LLC
Boxer Asset Management Inc.
MVA Investors, LLC
Braslyn Ltd.
View All
Comparable Firms State AUM ($B)
Boldhaven Management LLP
1.4
Needham Investment Management LLC
NY 1.4
Columbus Hill Capital Management LP
NJ 1.4
Tree Line Advisors Hong Kong Ltd
1.4
Paradice Investment Management LLC
CO 1.4
AFBI LP
FL 1.4
Greenbrier Partners Capital Management LLC
TX 1.4
Metacapital Management LP
NY 1.4
Dendur Capital LP
NY 1.4
Par Capital Management Inc
MA 1.4
Terms | Privacy | Guide
tony@aum13f.com